Q2 2023 · 13F-HR
Eagle Health Investments LPholdings as filed
Filed 2023-08-14 · accession 0001172661-23-003066
$534.8M
Reported value
27
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 46266C105 | IQV | IQVIA HLDGS INC | $49.3M | 9.22% | 219,495 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $46.6M | 8.71% | 186,200 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $41.3M | 7.72% | 172,085 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $37.7M | 7.05% | 170,838 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $31.0M | 5.79% | 165,300 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $29.8M | 5.58% | 87,290 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $29.0M | 5.42% | 595,694 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MED INC | $26.3M | 4.91% | 1,200,385 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $26.0M | 4.86% | 136,756 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $25.1M | 4.69% | 64,400 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $23.6M | 4.42% | 72,843 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $21.2M | 3.97% | 253,200 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $20.9M | 3.90% | 162,400 | Common | SOLE |
| 148806102 | CTLTEUR | CATALENT INC | $19.9M | 3.73% | 459,621 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $19.5M | 3.64% | 232,032 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $15.9M | 2.98% | 445,161 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $11.9M | 2.23% | 337,218 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $11.1M | 2.08% | 97,340 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $8.2M | 1.52% | 1,214,860 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $7.9M | 1.48% | 437,911 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $7.9M | 1.47% | 320,325 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $7.6M | 1.42% | 267,630 | Common | SOLE |
| 13781Y103 | — | CANO HEALTH INC | $6.0M | 1.12% | 4,290,901 | Common | SOLE |
| 36118A100 | — | FUSION PHARMACEUTICALS INC | $3.2M | 0.59% | 680,370 | Common | SOLE |
| 03044L105 | — | AMERICAN WELL CORP | $2.9M | 0.55% | 1,395,039 | Common | SOLE |
| 730541109 | — | POINT BIOPHARMA GLOBAL INC | $2.8M | 0.52% | 306,142 | Common | SOLE |
| 14171W103 | — | CAREMAX INC | $2.2M | 0.42% | 714,755 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.